packageRiociguat

riociguat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Riociguat is a drug used to treat pulmonary hypertension and chronic pulmonary heart disease. It is authorised in the European Union for pulmonary hypertension and is an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q2154494 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:riociguat
ATC codes:C02KX05
DrugBank:DB08931
PubChem CID:11304743
ChEBI:76018
Wikidata:Q2154494
formula:C20H19FN8O2
molar mass:422.424 g/mol (PubChem CID 11304743)
logP:1.6 (Drugs.Common 25.09, not verified)

Metabolites

M1M1molar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
M1metabolite: M1